STK11 and ovarian carcinoma: Taken together, our results demonstrate that LKB1-AMPK signalling appears to be intact and active in metastatic epithelial ovarian cancer, and that the overall metabolic state is altered in ovarian cancer spheroids with a concomitant response of activated LKB1-AMPK signalling.